Overview of Dr. Waintraub
Dr. Stanley Waintraub is an oncologist in Hackensack, NJ and is affiliated with Hackensack Meridian Health Hackensack University Medical Center. He received his medical degree from New York Medical College and has been in practice 40 years. Dr. Waintraub accepts several types of health insurance, listed below. He is one of 130 doctors at Hackensack Meridian Health Hackensack University Medical Center who specialize in Oncology. He has more than 20 publications and over 200 citings.
Office
92 2nd Street
Hackensack, NJ 07601- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1980 - 1981
- New York Medical College (Metropolitan)Residency, Internal Medicine, 1978 - 1980
- New York Medical CollegeClass of 1977
- Brooklyn College of CUNYB.S., 1974
Certifications & Licensure
- NY State Medical License 1978 - 2026
- NJ State Medical License 1983 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
- America's Top Doctors Castle Connolly, 2010-2014
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- Join now to see all
Clinical Trials
- Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Start of enrollment: 2013 Feb 26
Publications & Presentations
PubMed
- 3 citationsCombining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.Maher Albitar, Hong Zhang, Ahmad Charifa, Andrew Ip, Wanlong Ma, James McCloskey, Michele Donato, David Siegel, Stanley Waintraub, Martin Gutierrez, Andrew Pecora, And...> ;Heliyon. 2023 May 1
- 1 citationsHomologous Recombination Abnormalities Associated WithMutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data.Maher Albitar, Hong Zhang, Andrew Pecora, Stanley Waintraub, Deena Graham, Mira Hellmann, Donna McNamara, Ahmad Charifa, Ivan De Dios, Wanlong Ma, Andre Goy> ;Breast Cancer. 2023 Jan 1
- 8 citationsDifferential impact of cognitive computing augmented by real world evidence on novice and expert oncologists.Donna M. McNamara, Stuart L. Goldberg, Lisa M. Latts, Deena Graham, Stanley E. Waintraub, Andrew D. Norden, Cody Landstrom, Andrew L. Pecora, John Hervey, Eric V Schul...> ;Cancer Medicine. 2019 Sep 11
- Join now to see all
Journal Articles
- The Use of Anti-D In Immune Thrombocytopenic Purpura As A Means To Prevent Splenectomy Case Reports From Two University Hospital Medical CentersWaintraub, S.E. and Brody, J.I., Seminars In Hematology, 1/1/2009
- Colonic adenomas detected by FDG PET scansFelig DM, Sedarat A, Agress H, Waintraub SE, Gastrointestinal Endoscopy, 1/1/2002
- Phase II Study To Evaluate The Efficacy of Weekly Paclitaxel (P) In Patients With Metastatic Breast Cancer (MBC) Who Have Failed Prior Anthracycline (A) +/- Taxane (T)...S.E. Waintraub, S. Cantwell, J. DeVries,, JCO, 1/1/1999
- Join now to see all
Abstracts/Posters
- The role of preoperative neoadjuvant cytoreductive dose dense bevacizumab plus docetaxel followed by bevacizumab-doxorubicin-cyclophosphamide regimen in locally advanc...Waintraub, SE, Tuchman, V, Proceedings of ASCO, 1/1/2009
- The role of maintenance bevacizumab in patients with metastatic breast cancer treated with chemotherapy and bevacizumab upon achieving complete response or maximal rad...Waintraub SE, Tuchman V, ASCO, 1/1/2008
- Phase II Trial To Study The Efficacy And Toxicity Of Combined Docetaxel, Carboplatin, Plus Or Minus Trastuzumab Administered Weekly In Patients With HER2/neu Positive/...Waintraub D, Sica V, Proceedings of ASCO, 1/1/2004
- Join now to see all
Press Mentions
- Genetic Testing Helps Entire New Jersey Family Avoid CancersSeptember 22nd, 2021
Professional Memberships
- Member
- Member
- Fellow
Hospital Affiliations
- Hackensack Meridian Health Hackensack University Medical CenterHackensack, New Jersey
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
Amerihealth HMO
AmeriHealth PPO
BCBS Alabama PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPOHIP of New York - Select PPO
Horizon BCBS Direct Access
Horizon BCBS HMO
Horizon BCBS POS
Horizon BCBS PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: